Oligoprogression During First-Line Treatment of Metastatic Hormone-Sensitive Prostate Cancer: Comparative Outcomes of Metastasis-Directed Radiotherapy and Systemic Treatment Change.

J Clin Med · 2026 · PMC13116737 · PMID 42074868

Europe PMC DOI

hedged sentences

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

borderline significancep = 0.052so close (0.05 < p ≤ 0.1)

The metastatic risk group demonstrated borderline significance ( p = 0.052).

also in 7,017 other papers

did not reach statistical significanceno p-value reported

Although median OS was numerically longer in the RT group, this difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.